Document Type

Article

Publication Date

21-6-2003

Keywords

Antiretroviral Therapy, Highly Active, Developing Countries, Drug Industry, Drug Prescriptions, HIV Infections, Health Policy, Humans, Interprofessional Relations, Private Sector

Comments

This article is also available from www.bmj.com

Abstract

Action is underway to increase access to antiretroviral drugs, especially in countries with high rates of HIV

The role of private providers is largely ignored, although they are an important source of care for stigmatising diseases in many poor countries

Evidence is emerging that antiretroviral drugs are leaking into formal and informal private markets

Uncontrolled use of drugs in the private sector will lead to rapid development of HIV resistance

Countries require guidance and support from international policy makers and pharmaceutical companies to implement strategies for working with private providers

Disciplines

Medicine and Health Sciences

Citation

Brugha R. Antiretroviral treatment in developing countries: the peril of neglecting private providers. British Medical Journal. 2003;326(7403)1382-4.

PubMed ID

12816829

DOI Link

10.1136/bmj.326.7403.1382